FRANKLIN FINANCIAL SERVICES CORPORATION financials

FRAF CIK 0000723646

Source: EDGAR filings · Built 2026-06-02T03:05:02Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Debt -123.73M -199.01M 1.34M -39.13M 241.71M -32.26M
Return on Equity (ROE) 12.11% 7.67% 10.29% 13.08% 12.49% 8.82%
Return on Assets (ROA) 0.95% 0.51% 0.74% 0.88% 1.11% 0.83%
Debt-to-Equity 0.02× 0.03× 0.19× 0.23× 2.65× 0.17×
Effective Tax Rate 19.19% 16.64% 13.68% 14.62% 14.76% 1.98%
Cash Conversion Ratio 1.20× 1.96× 1.95× 1.69× 1.34× 0.50×
Accruals Ratio -0.00× -0.00× -0.01× -0.01× -0.00× 0.00×

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 10.59× 11.91× 10.18× 10.74× 7.49× 9.23×
P/B 1.28× 0.91× 1.04× 1.39× 0.94× 0.82×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Income Tax Expense (Benefit) 5.04M 2.22M 2.15M 2.56M 3.40M 258.00K
Net Income (Loss) Attributable to Parent 21.23M 11.10M 13.60M 14.94M 19.62M 12.80M
Earnings Per Share, Basic $4.76 $2.52 $3.11 $3.38 $4.44 $2.94
Weighted Average Number of Shares Outstanding, Basic 4.46M 4.40M 4.37M 4.42M 4.42M 4.36M
Earnings Per Share, Diluted $4.74 $2.51 $3.10 $3.36 $4.42 $2.93
Weighted Average Number of Shares Outstanding, Diluted 4.48M 4.41M 4.38M 4.45M 4.44M 4.37M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 127.72M 203.61M 23.14M 64.90M 175.15M 57.15M
Assets 2.24B 2.20B 1.84B 1.70B 1.77B 1.54B
Liabilities 2.06B 2.05B 1.70B 1.59B 1.62B 1.39B
Stockholders' Equity Attributable to Parent 175.24M 144.72M 132.14M 114.20M 157.06M 145.18M
Common Stock, Shares, Outstanding 4.48M 4.43M 4.37M 4.39M 4.44M 4.39M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 25.44M 21.75M 26.57M 25.24M 26.35M 6.43M
Net Cash Provided by (Used in) Investing Activities -107.02M -184.37M -178.27M -95.06M -133.94M -277.31M
Payments for Repurchase of Common Stock 1.10M 827.00K 2.39M 3.33M 1.19M 1.17M
Net Cash Provided by (Used in) Financing Activities 5.69M 343.08M 109.94M -40.44M 225.59M 244.20M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (FRAF CIK 0000723646), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SPRY

ARS Pharmaceuticals, Inc.

CC

Chemours Co

KRYS

Krystal Biotech, Inc.